Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found.
from NDTV News - World-news https://ift.tt/3nX8fwP
from NDTV News - World-news https://ift.tt/3nX8fwP
World
![World]()
Reviewed by Latest trending news
on
October 15, 2020
Rating:
No comments:
Note: only a member of this blog may post a comment.